HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

YSL Beaute

This article was originally published in The Rose Sheet

Executive Summary

Alain Denoly named CEO, YSL Beaute U.S. subsidiary, Gucci Group announces. Previously managing director of CFEB Sisley, Denoly will report to YSL Beaute CEO Chantal Roos. Denoly relieves YSL Beaute Exec VP-International Philippe Tourille, who supervised activities in the U.S. following resignation of Don Loftus in February. Loftus left the firm "to give new direction" to his career (1"The Rose Sheet" Feb. 12, In Brief). Gucci purchased the U.S. beauty business from Artemis for $1 bil. in November 1999

You may also be interested in...



YSL Beaute

Don Loftis resigns as CEO, YSL Beaute U.S. subsidiary in order to "give new direction" to his career, firm announces. YSL Beaute CEO Chantal Roos will act as CEO of the division, and Exec VP International Philippe Tourille will supervise all activities in the U.S. until a new exec is appointed. High profile candidate being sought, as firm plans to "step up" brand credibility worldwide

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
UsernamePublicRestriction

Register

RS009024

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel